1. Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero® to reduce meningococcal group B disease in Germany. Issue 29 (17th June 2016) Authors: Christensen, Hannah; Irving, Tom; Koch, Judith; Trotter, Caroline L.; Ultsch, Bernhard; Weidemann, Felix; Wichmann, Ole; Hellenbrand, Wiebke Journal: Vaccine Issue: Volume 34:Issue 29(2016) Page Start: 3412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗